The DOI matches its Crossref record; 321 of the 321 references it cites were found in a registry or an index.
Targeted Cancer Stem Cell Therapeutics: An Update
Abstract
Cancer stem cells (CSCs) have become a key player in the growth of tumors, the spread of cancer, and the resistance to therapeutic interventions. Targeting these elusive cell populations has the potential to fundamentally alter cancer treatment plans. CSCs, also known as tumor-initiating cells (TICs), are thought to play a role in both medication resistance and cancer recurrence. This is explained by their capacity to regenerate themselves and change into different kinds of cancer cells. Due to their higher expression of ATP-binding cassette (ABC) membrane transporters, enhanced epithelial to mesenchymal (EMT) characteristics, improved immune evasion, activation of survival signaling pathways, and improved DNA repair mechanisms, CSCs exhibit extraordinary resistance to therapies. This comprehensive analysis delves into advancements in the domain of Targeted Cancer Stem Cell Therapeutics, concentrating on unraveling the distinctive traits of CSCs and the therapeutic methods devised to eliminate them.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Relative to normal fibroblasts, CAFs have increased production of ECM, cytokines, and growth factors, including PDGF, HGF, VEGF, and CXCL12 [71].”
From Mechanisms and Strategies to Overcome Drug Resistance in Colorectal Cancer (2025) · cites this paper as [71]
In the citing paper
“They also have a higher expression of ABC transporters, enhanced DNA repair mechanisms, and improved immune evasion [71].”
From Mechanisms and Strategies to Overcome Drug Resistance in Colorectal Cancer (2025) · cites this paper as [71]
In the citing paper
“EMT is also associated with a CSC-like phenotype in CRC tumors, while colorectal CSCs are reported to have enhanced EMT characteristics [71].”
From Mechanisms and Strategies to Overcome Drug Resistance in Colorectal Cancer (2025) · cites this paper as [71]
In the citing paper
“While numerous preclinical studies have shown that SMO inhibition can limit therapy resistance, tumor recurrence, and metastasis in various malignancies, the results in CRC are less clear [71].”
From Mechanisms and Strategies to Overcome Drug Resistance in Colorectal Cancer (2025) · cites this paper as [71]
Citations
Cites
1 retracted
Xiao, J., Yang, B., Lin, H., Lu, Y., Luo, X., & Wang, Z. (2007) · Journal of Cellular Physiology · doi:10.1002/jcp.21062 · Cited by 193
RetractedHanahan, D., & Weinberg, R. A. (2000) · Cell · doi:10.1016/s0092-8674(00)81683-9 · Cited by 29,219
Induction of Pluripotent Stem Cells from Adult Human Fibroblasts by Defined Factors
Takahashi, K., Tanabe, K., Ohnuki, M., Narita, M., Ichisaka, T., Tomoda, K., & Yamanaka, S. (2007) · Cell · doi:10.1016/j.cell.2007.11.019 · Cited by 20,221
Siegel, R. L., Miller, K. D., & Jemal, A. (2018) · CA: A Cancer Journal for Clinicians · doi:10.3322/caac.21442 · Cited by 16,579
Prospective identification of tumorigenic breast cancer cells
Al-Hajj, M., Wicha, M. S., Benito-Hernandez, A., Morrison, S. J., & Clarke, M. F. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0530291100 · Cited by 10,370
Epithelial-Mesenchymal Transitions in Development and Disease
Thiery, J. P., Acloque, H., Huang, R. Y. J., & Nieto, M. A. (2009) · Cell · doi:10.1016/j.cell.2009.11.007 · Cited by 9,931
MicroRNA signatures in human cancers
Calin, G. A., & Croce, C. M. (2006) · Nature Reviews Cancer · doi:10.1038/nrc1997 · Cited by 7,590
Targeting HIF-1 for cancer therapy
Semenza, G. L. (2003) · Nature Reviews Cancer · doi:10.1038/nrc1187 · Cited by 6,717
Identification of stem cells in small intestine and colon by marker gene Lgr5
Barker, N., van Es, J. H., Kuipers, J., Kujala, P., van den Born, M., Cozijnsen, M., Haegebarth, A., Korving, J., Begthel, H., Peters, P. J., et al. (2007) · Nature · doi:10.1038/nature06196 · Cited by 5,687
Wnt/β-Catenin Signaling: Components, Mechanisms, and Diseases
MacDonald, B. T., Tamai, K., & He, X. (2009) · Developmental Cell · doi:10.1016/j.devcel.2009.06.016 · Cited by 5,583
Research works printed but not linked: 13
- Yuan J.; Narayanan L.; Rockwell S.; Glazer P.M.; Diminished dna repair and elevated mutagenesis in mammalian cells exposed to hypoxia and low PH 1. Cancer Res 2000,60,4372-4376
- Turley H.; Hypoxia-inducible Factors HIF-1?? and HIF-2?? in Head and Neck Cancer Relationship to Tumor Biology and Treatment Outcome in Surgically Resected Patients. Cancer Res 2002,62(9),2493-2497
- Kang Y.; Massagué J.; Cancer Biology and Genetics Program and Howard Hughes Medical Institute Sarcoma Appearance; Thiery 2004,118
- Gerweck L.E.; Cellular PH gradient in tumor versus normal tissue: Potential exploitation for the treatment of cancer. Cancer Res 1996,56(6),1194-1198
- Vincent A.; Kwan Ng Y.; Side population in human lung cancer cell lines and tumors is enriched with stem-like. Cancer Cells 2007
- Li Sun Y; Patel A; Kumar P; Sheng Chen Z.; Role of ABC transporters in cancer chemotherapy. CACA 2012,31(2),1-8
- Zhang X.; Lou Y.; Zheng X.; Wang H.; Sun J.; Dong Q.; Han B.; Wnt blockers inhibit the proliferation of lung cancer stem cells. Drug Des Devel Ther 2015,9,2399-2407
- Campbell V.; Copland M.; Hedgehog signaling in cancer stem cells: a focus on hematological cancers. Stem Cells Cloning 2015,8,27-38
- Chen Y; CD133(þ) EpCAM(þ) phenotype possesses more characteristics of tumor initiating cells in hepatocellular carcinoma Huh7 cells. Int J Biol Sci 2012,8,992e1004
- Cosgun K.N.N.; Lgr5 functions as negative regulator of Wnt signaling in B cells and is critical for self-renewal of normal and transformed B cells. Blood 2017,130,3989
- Jerabek S.; Merino F.; Schöler H.R.; Cojocaru V.; OCT4: Dynamic DNA binding pioneers stem cell pluripotency, Biochimica et Biophysica Acta (BBA) -. Gene Regulatory Mechanisms 2014,1839,138-154
- Kar S.; Investigation of the Epigenetic Regulators and Signaling Pathways Influencing Pluripotency Inducing Transcription Factors Mediated Tumorigenesis. PhD Thesis National Institute of Technology Rourkela, Rourkela, Odisha, India 2017
- Al-Hajj M.; Wicha M.S.; Benito-Hernandez A.; Morrison S.J.; Clarke M.F.; Prospective identification of tumorigenic breast cancer cells. Proc Natl Acad Sci 2003,100(7),3983-3988 · DOI · Paper page
Cited by
Mechanisms and Strategies to Overcome Drug Resistance in Colorectal Cancer
Haynes, J., & Manogaran, P. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms26051988 · Cited by 82
“A second key approach for targeting colorectal CSCs involves the suppression of specific signaling pathways that are critical for CSC maintenance and proliferation [69,71,72].”
InfluentialAdvances in Nanomedicine for Targeting Cancer Stem Cells and Overcoming Therapeutic Resistance
Zhang, Z., Chen, B., Liu, Y., Zhang, K., Wei, Z., Dai, Y., & Liu, C. (2025) · ACS Nano · doi:10.1021/acsnano.5c02321 · Cited by 13
Pal, R., Matada, G. S. P., & Teli, G. (2025) · Chemistry & Biodiversity · doi:10.1002/cbdv.202402907 · Cited by 4
Cheng, X., Xu, J., Gu, H., Chen, G., & Wu, L. (2024) · Experimental Cell Research · doi:10.1016/j.yexcr.2024.114167 · Cited by 2
What we need in colorectal cancer research, and why?
Badiola, I. (2024) · Advances in genetics · doi:10.1016/bs.adgen.2024.08.001
Metadata
- Authors
- Fatima, N., Umar, M., Ambreen, S., Shaququzzaman, M., Alam, M. M., & Ali, R.
- Affiliations
- Delhi Pharmaceutical Science and Research University (IN)
- Department of Pharmaceutical Chemistry, School of Pharmaceutical Education and Research, Jamia Hamdard, Hamdard Nagar, New Delhi, 110062, India
- Jamia Hamdard (IN)
- Corresponding author
- Ali, Ruhi
- Venue
- Current Topics in Medicinal Chemistry
- Publisher
- Bentham Science Publishers Ltd.
- Published
- 2025-03
- Volume
- 25
- Issue
- 8
- Pages
- 842-870
- ISSN
- 1568-0266 (ISSN-L)
- OpenAlex
- W4391310675
- Cited by
- 6
- References
- 321
- Citations by year
- 2026: 1 · 2025: 3
- FWCI
- 0.32
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Current Topics in Medicinal Chemistry (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Oncology › Cancer Cells and Metastasis
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Mesenchymal stem cell research
- Health Sciences › Medicine › Oncology › Glioma Diagnosis and Treatment
- Keywords
- cancer stem cells, drug resistance, tumor recurrence, ABC transporters, epithelial-mesenchymal transition, immune evasion, DNA repair, survival signaling pathways
- MeSH terms
- Animals, Antineoplastic Agents, Humans, Neoplasms, Neoplastic Stem Cells
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Targeted Cancer Stem Cell Therapeutics: An Update. https://app.cochat.ai/papers/10.2174/0115680266275014240110071351
- The paper
- Fatima, N., Umar, M., Ambreen, S., Shaququzzaman, M., Alam, M. M., & Ali, R. (2025). Targeted Cancer Stem Cell Therapeutics: An Update. Current Topics in Medicinal Chemistry. https://doi.org/10.2174/0115680266275014240110071351
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.